ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Editorial Article: A Simple Step to Improve Your CRISPR/Cas9 Results – SelectScience

SelectScienceEditorial Article: A Simple Step to Improve Your CRISPR/Cas9 ResultsSelectScienceCRISPR/Cas9 is a genetic manipulation method, and the development of this revolutionary genome editing tool has enabled scientists around the world to make mo… Continue reading

2018-02-14 Michael Zand NEWS

Leading Cancer Organizations Provide Guidance on Understanding and Managing Immunotherapy Side Effects – PR Newswire (press release)

PR Newswire (press release)Leading Cancer Organizations Provide Guidance on Understanding and Managing Immunotherapy Side EffectsPR Newswire (press release)"While novel immunotherapies allow for life-extending therapy for selected forms of cancer,… Continue reading

2018-02-14 Michael Zand NEWS

Aging Clues Found in Stem Cell Ribosomal DNA – Genetic Engineering & Biotechnology News

Continue reading

2018-02-14 Michael Zand NEWS

A map app to track stem cells – Phys.Org

Phys.OrgA map app to track stem cellsPhys.OrgResearchers who work with stem cells have ambitious goals. Some want to cure cancer or treat heart disease. Others want to grow the tissues and organs that patients need for transplants. Some groups are even… Continue reading

2018-02-14 Michael Zand NEWS

Scientist Painstakingly Documents His Own DIY Gene Therapy – Popular Mechanics

Popular MechanicsScientist Painstakingly Documents His Own DIY Gene TherapyPopular MechanicsDIY gene therapy is far from the mainstream, but the numbers of people who are attempting to genetically engineer their own bodies is rising. People like Trista… Continue reading

2018-02-14 Michael Zand NEWS

Editas Medicine (NASDAQ:EDIT) versus Arena Pharmaceuticals (ARNA) Head-To-Head Contrast – StockNewsTimes

Editas Medicine (NASDAQ:EDIT) versus Arena Pharmaceuticals (ARNA) Head-To-Head ContrastStockNewsTimesIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a prote… Continue reading

2018-02-14 Michael Zand NEWS

DowDuPont revealed as the surprise leader in global CRISPR patents; study points to potential trouble ahead – IAM (blog)


Genetic Engineering & Biotechnology News

Aging Clues Found in Stem Cell Ribosomal DNA
Genetic Engineering & Biotechnology News
Studies have confirmed that in yeast cells, at least, this rDNA instability and gene copy loss underlies aging, via a process known as replicative senescence. What isn’t yet known, however, is whether rDNA instability contributes to aging in …

and more »

Continue reading

2018-02-14 Michael Zand NEWS

DowDuPont revealed as the surprise leader in global CRISPR patents; study points to potential trouble ahead – IAM (blog)


IAM (blog)

DowDuPont revealed as the surprise leader in global CRISPR patents; study points to potential trouble ahead
IAM (blog)
A new study of the global CRISPR patent landscape released today provides the most detailed insight yet into how entities are seeking to protect their inventions relating to the revolutionary technology. Speaking exclusively to IAM, the report’s author …

and more »

Continue reading

2018-02-14 Michael Zand NEWS
  • 1
  • …
  • 529
  • 530
  • 531
  • 532
  • 533
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

IAM (blog)

DowDuPont revealed as the surprise leader in global CRISPR patents; study points to potential trouble ahead
IAM (blog)
A new study of the global CRISPR patent landscape released today provides the most detailed insight yet into how entities are seeking to protect their inventions relating to the revolutionary technology. Speaking exclusively to IAM, the report’s author …

and more »